
MERIT: Specialized clinical trial endpoint services for ophthalmology, respiratory, and oncology sectors.
Founded with a mission to enhance the accuracy and reliability of clinical trial endpoints, MERIT specializes in providing endpoint services for ophthalmology, respiratory, and oncology therapeutic areas. The company collaborates with contract research organizations (CROs), pharmaceutical, and biotech firms to support multi-regional clinical trials. MERIT's suite of services includes reading center services, clinical operations, and specialized software solutions like EXCELSIOR Imaging Software, aimed at ensuring precise data collection and analysis.
MERIT's leadership team comprises experts with extensive experience in clinical research and therapeutic specialties. The company has formed strategic partnerships with leading CROs and sponsors, bolstering its reputation in the industry. Notable achievements include successful collaborations on high-profile clinical trials and the development of innovative software tools that streamline trial processes. MERIT's impact is evident in its contribution to advancing medical research and improving patient outcomes across its specialized therapeutic areas.

Endpoint Clinical

Clinical Research IO

Clinical.Ly
clinical.ly

Accelerated Vision Group

Medable
medable.com

Citruslabs
citruslabs.com

CRO Analytics

Medrio
medrio.com

ClinOne
clinone.com

On-Time Trials
ontimetrials.com

Algorics

Vial
vialtrials.com

High Enroll
highenroll.org

ObvioHealth
obviohealth.com

SubjectWell
subjectwell.com
Companies similar to Merit CRO include Endpoint Clinical, Clinical Research IO, Clinical.Ly and Accelerated Vision Group.
Merit CRO was founded in 2012.
Merit CRO's headquarters is located in Madison, WI, US.
Merit CRO's most recent funding round was for $1.1M (USD) in July 2023.
As of Jul 20, 2023, Merit CRO has raised a total of $3.7M (USD).
Merit CRO has 99 employees as of Feb 5, 2024.